治疗急性缺血性脑卒中的新进展主要是药物治疗,但行之有效而且可以广泛应用的药物是有限的。经过大量失败的临床试验,目前还没有找到一种神经保护剂可以用于急性脑卒中的治疗。虽然组织纤维蛋白原激活剂(Rtpa)在美国和加拿大可以获取,但是绝大多数符合治疗标准的病人仍然不能应用这一治疗,而且在国际研究领域 New advances in the treatment of acute ischemic stroke are mainly drug treatment, but effective and widely available drugs are limited. After a large number of failed clinical trials, no neuroprotective agent has been found yet for the treatment of acute stroke. Although tissue fibrinogen activators (Rtpa) are available in the United States and Canada, the vast majority of patients who meet the criteria for treatment are still unable to use this treatment and are in the international research arena